Literature DB >> 20357706

Establishing the validity of a spiritual distress scale for cancer patients hospitalized in southern Taiwan.

Ya-Lie Ku1, Shih-Ming Kuo, Ching-Yi Yao.   

Abstract

The present study was conducted to establish the validity of the spiritual distress scale (SDS), a scale developed as part of a qualitative study in which 20 cancer patients were interviewed about spiritual needs in 2003-2004. The SDS has four domains: relationship with self, relationship with others, relationship with God, and attitude towards death A measurement study was conducted whereby 85 patients completed the SDS during their hospitalization in the oncology unit of a medical centre in southern Taiwan. The SDS, including four domains of sub-scales, was broader than other spiritual scales in the literature that only contained one or two domains and focused on the health area. The SDS has established the adequate content and construct validity. Further training of nurses for assessing spiritual distress of cancer patients using the SDS would be recommended for future study. The established content and construct validity of the SDS could be applied in oncology for nurses to assess spiritual distress of cancer patients.

Entities:  

Mesh:

Year:  2010        PMID: 20357706     DOI: 10.12968/ijpn.2010.16.3.47325

Source DB:  PubMed          Journal:  Int J Palliat Nurs        ISSN: 1357-6321


  2 in total

1.  Intercessory Prayer on Spiritual Distress, Spiritual Coping, Anxiety, Depression and Salivary Amylase in Breast Cancer Patients During Radiotherapy: Randomized Clinical Trial.

Authors:  Talita Prado Simão Miranda; Sílvia Caldeira; Harley Francisco de Oliveira; Denise Hollanda Iunes; Denismar Alves Nogueira; Erika de Cássia Lopes Chaves; Emília Campos de Carvalho
Journal:  J Relig Health       Date:  2020-02

Review 2.  [The Development of a Tool for Assessment of Spiritual Distress in Cancer Patients].

Authors:  Jin Sook Kim; Il-Sun Ko; Su Jin Koh
Journal:  J Korean Acad Nurs       Date:  2022-02       Impact factor: 0.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.